Webinars

Biopharma Opportunities and Obligations

Gain insights on the value of public/private partnership in developing platforms for pandemic preparedness.

Rapidly create single-use biomanufacturing capacity

Improving Biomanufacturing Resilience

Understand new biopharma strategies and industry collaborations to achieve resilient biomanufacturing.

Global Biopharma Resilience Index home page banner

Resilience Index: New Findings

New findings reveal how government policy and regulation can build biopharma resilience.

The BioPharma Resilience Index

Making policy work

To deliver life-saving drugs more quickly, biopharma must work in harmony with governments and regulators.

Scientist in FlexFactory

Flexfactory™ platform

Configurable biomanufacturing train designed for your current and future capacity needs.

KUBio BSL2 Rendering campus

KUBio™ facilities

Modular, turnkey biomanufacturing solutions for your capacity expansion.

KUBIO web banner

KUBio™ box environments

Supporting rapid response demands for biomanufacturing capacity.

SA25 Aseptic Filling Workcell for pharmaceutical vial, syringe and cartridge filling

Aseptic filling

Standardized, closed, robotic aseptic filling workcells for filling drug products.

Figurate

Figurate™ automation

Offering configurable platforms to connect your bioprocessing environment.

KUBio mAb Manufacturing Facility

Bioprocess capacity solutions

Adapt to evolving biomanufacturing demands and rapid capacity needs with modular facilities and integrated, flexible manufacturing platforms.

Resource center

Featured article
Building biopharma resilience through education and training

Continuing education and additional job training are key to bridge biopharma skills gaps, grow talent and provide resilient biopharmaceutical supply chains. Read this article for new insights from NIBRT, Teesside University’s National Horizons Centre (NHC) and other leaders to learn how new approaches for talent sourcing and to fill specialized-skills gaps can grow biomanufacturing resilience.

Popular articles
Bridging the skills gap in biopharma

Understand how you can ensure your staff is up to date on today’s complex bioprocessing techniques and technologies.

Standardized approaches to biomanufacturing

Lower costs, improve outcomes and alter the landscape of the global pharmaceutical market.

Viral vector manufacturing: the key to the success of gene therapy

Understand current challenges and trends influencing design considerations for viral vector manufacturing facilities and how they can impact companies developing cell and gene therapies.

Staying flexible in biomanufacturing with optionality

The biopharma industry offers big rewards – but it poses big risks, too. Rather than fearing the unknown, the concept of optionality can help you better manage it.

mRNA production

Increasing mRNA capabilities and capacity for growing market needs.

Viral vector therapies

Designing agile manufacturing with an integrated drug substance/drug product ecosystem.

Prepare for the challenges of the future

Start preparing for tomorrow today. Contact Cytiva’s team of biomanufacturing experts to take your capacity planning to the next level.

Something went wrong!
Thank you!